WO2006107806A3 - Stannsoporfin compositions and administration - Google Patents

Stannsoporfin compositions and administration Download PDF

Info

Publication number
WO2006107806A3
WO2006107806A3 PCT/US2006/012185 US2006012185W WO2006107806A3 WO 2006107806 A3 WO2006107806 A3 WO 2006107806A3 US 2006012185 W US2006012185 W US 2006012185W WO 2006107806 A3 WO2006107806 A3 WO 2006107806A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
stannsoporfin
administration
pharmaceutical compositions
methods
Prior art date
Application number
PCT/US2006/012185
Other languages
French (fr)
Other versions
WO2006107806A2 (en
Inventor
Philip C Lang
George S Drummond
Original Assignee
Infacare Pharmaceutical Corp
Philip C Lang
George S Drummond
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/096,359 external-priority patent/US20060222668A1/en
Priority to AU2006232330A priority Critical patent/AU2006232330A1/en
Priority to EP06749109A priority patent/EP1865777A4/en
Priority to BRPI0609794-4A priority patent/BRPI0609794A2/en
Priority to NZ562158A priority patent/NZ562158A/en
Priority to CA002602794A priority patent/CA2602794A1/en
Application filed by Infacare Pharmaceutical Corp, Philip C Lang, George S Drummond filed Critical Infacare Pharmaceutical Corp
Priority to JP2008504470A priority patent/JP2008534618A/en
Priority to MX2007012166A priority patent/MX2007012166A/en
Priority to EA200702136A priority patent/EA013597B1/en
Publication of WO2006107806A2 publication Critical patent/WO2006107806A2/en
Publication of WO2006107806A3 publication Critical patent/WO2006107806A3/en
Priority to IL186337A priority patent/IL186337A0/en
Priority to NO20075508A priority patent/NO20075508L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pharmaceutical compositions including stannsoporfin, drug products incorporating pharmaceutical compositions, methods of making pharmaceutical compositions, and methods of treating hyperbilirubinemia with drug products and compositions are disclosed.
PCT/US2006/012185 2005-04-01 2006-03-31 Stannsoporfin compositions and administration WO2006107806A2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
EA200702136A EA013597B1 (en) 2005-04-01 2006-03-31 Stannsoporfin compositions and administration
EP06749109A EP1865777A4 (en) 2005-04-01 2006-03-31 Stannsoporfin compositions and administration
BRPI0609794-4A BRPI0609794A2 (en) 2005-04-01 2006-03-31 pharmaceutical composition, drug product, method of manufacturing a pharmaceutical composition, method of decreasing bilirubin levels in a mammal, and method for increasing stanosporfin bioavailability following intramuscular administration in a human patient
NZ562158A NZ562158A (en) 2005-04-01 2006-03-31 Stannsoporfin compositions and administration
CA002602794A CA2602794A1 (en) 2005-04-01 2006-03-31 Stannsoporfin compositions and administration
AU2006232330A AU2006232330A1 (en) 2005-04-01 2006-03-31 Stannsoporfin compositions and administration
JP2008504470A JP2008534618A (en) 2005-04-01 2006-03-31 Stansoporfin composition and administration
MX2007012166A MX2007012166A (en) 2005-04-01 2006-03-31 Stannsoporfin compositions and administration.
IL186337A IL186337A0 (en) 2005-04-01 2007-10-07 Stannsoporfin compositions and administration
NO20075508A NO20075508L (en) 2005-04-01 2007-10-31 Stable Soporphine Preparations and Administration

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/096,359 US20060222668A1 (en) 2005-04-01 2005-04-01 Stannsoporfin compositions, drug products and methods of manufacture
US11/096,359 2005-04-01
US11/239,769 US20060222669A1 (en) 2005-04-01 2005-09-30 Stannsoporfin compositions and administration
US11/239,769 2005-09-30

Publications (2)

Publication Number Publication Date
WO2006107806A2 WO2006107806A2 (en) 2006-10-12
WO2006107806A3 true WO2006107806A3 (en) 2007-07-12

Family

ID=37073987

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/012185 WO2006107806A2 (en) 2005-04-01 2006-03-31 Stannsoporfin compositions and administration

Country Status (6)

Country Link
EP (1) EP1865777A4 (en)
KR (1) KR20080004531A (en)
AU (1) AU2006232330A1 (en)
CA (1) CA2602794A1 (en)
NO (1) NO20075508L (en)
WO (1) WO2006107806A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375216B2 (en) 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
PL2079472T3 (en) 2006-10-04 2012-01-31 Infacare Pharmaceutical Corp High-purity large-scale preparation of stannsoporfin
DK2691398T3 (en) 2011-03-30 2017-01-16 Infacare Pharmaceutical Corp Methods for synthesizing metal mesoporphyrins

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
US20040210048A1 (en) * 2002-06-04 2004-10-21 Wellspring Pharmaceutical Corporation Preparation of metal mesoporphyrin halide compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692440A (en) * 1985-03-25 1987-09-08 The Rockefeller University Therapeutic use of tin mesoporphyrin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
US20040210048A1 (en) * 2002-06-04 2004-10-21 Wellspring Pharmaceutical Corporation Preparation of metal mesoporphyrin halide compounds
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DRUMMOND ET AL.: "Prevention of Neonatal Hyperbilirumbinemia by Tin Protoporphyrin IX, a Potent Competitive Inhibitor of Heme Oxidation", PROC. NATL. ACAD. SCI. USA, vol. 78, no. 10, 1981, pages 6466 - 6470, XP003015383 *
See also references of EP1865777A4 *

Also Published As

Publication number Publication date
KR20080004531A (en) 2008-01-09
AU2006232330A1 (en) 2006-10-12
EP1865777A4 (en) 2008-07-16
CA2602794A1 (en) 2006-10-12
NO20075508L (en) 2007-10-31
EP1865777A2 (en) 2007-12-19
WO2006107806A2 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
WO2006099169A3 (en) Novel liposome compositions
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2009121039A3 (en) Administration of benzodiazepine compositions
WO2008039218A3 (en) Inhibitors of bruton's tyrosine kinase
EP1783137A4 (en) Galactose derivative, drug carrier and medicinal composition
WO2007050784A3 (en) Fixed ratio drug combination treatments for solid tumors
WO2007146426A3 (en) Nanoshells for drug delivery
WO2006124698A3 (en) Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting
NZ543661A (en) Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation
WO2007100905A3 (en) Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
WO2008022345A3 (en) Compositions and methods for inhibiting cytochrome p450
WO2010121177A3 (en) Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses
WO2011143201A3 (en) Ratiometric combinatorial drug delivery
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
WO2007144169A3 (en) Entacapone-derivatives
WO2006075256A3 (en) 9a-carbamoyl-ϝ-aminopropyl- and 9a-thiocarbamoyl-ϝ-aminopropyl-azalides with antimalarial activity
WO2009071690A3 (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
AU2003267581A1 (en) Drug delivery
WO2007146335A3 (en) Compounds and compositions for treatment of cancer
WO2007105015A3 (en) DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID
WO2008030818A3 (en) Novel liposome compositions
WO2007059116A3 (en) Geldanamycin derivatives and pharmaceutical compositions thereof
EP1503748A4 (en) Drugs for mitigating taxane-induced neurotoxicity

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680012779.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2602794

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2008504470

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: MX/a/2007/012166

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 562158

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 3766/KOLNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2006749109

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 186337

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2006232330

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2007/08892

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 1020077024891

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2006232330

Country of ref document: AU

Date of ref document: 20060331

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: RU

WWE Wipo information: entry into national phase

Ref document number: 200702136

Country of ref document: EA

ENP Entry into the national phase

Ref document number: PI0609794

Country of ref document: BR

Kind code of ref document: A2